Yasuhiro Kawasaki Selected Research

Temazepam (Nocturne)

3/2010	Superior temporal gyrus volume in antipsychotic-naive people at risk of psychosis.
9/2009	An MRI study of the superior temporal subregions in first-episode patients with various psychotic disorders.
4/2007	Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report.
4/2006	Morphologic alterations of the parcellated superior temporal gyrus in schizophrenia spectrum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Kawasaki Research Topics

Disease

24	Schizophrenia (Dementia Praecox) 01/2019 - 05/2002
7	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 04/2007
1	Alzheimer Disease (Alzheimer's Disease) 12/2021
1	Infections 09/2020
1	Whooping Cough (Pertussis) 09/2020
1	With Papillary Renal Neoplasia Papillary Thyroid Carcinoma 09/2020
1	Hypertension (High Blood Pressure) 04/2017
1	Hyperthermia 04/2017
1	Catatonia 04/2017
1	Hallucinations (Hallucination) 04/2017
1	Neuroleptic Malignant Syndrome 04/2017
1	Tachycardia (Tachyarrhythmias) 04/2017
1	Disease Progression 04/2017
1	Mental Disorders (Mental Disorder) 01/2017

Drug/Important Bio-Agent (IBA)

11	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 09/2006
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 02/2004
4	Temazepam (Nocturne)FDA LinkGeneric 03/2010 - 04/2006
3	Biological ProductsIBA 01/2019 - 01/2010
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2008 - 04/2008
2	Olanzapine (Zyprexa)FDA Link 04/2008 - 09/2006
2	acceleratory factor from growth hormone (AcG)IBA 12/2002 - 05/2002
1	MacrolidesIBA 09/2020
1	P-2 (P 2)IBA 01/2019
1	SmokeIBA 01/2019
1	BenzodiazepinesIBA 04/2017
1	Creatine Kinase (Creatine Phosphokinase)IBA 04/2017
1	Dantrolene (Dantrium)FDA LinkGeneric 04/2017
1	Haloperidol (Haldol)FDA LinkGeneric 04/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	tandospironeIBA 12/2010
1	perospironeIBA 06/2009
1	Polytetrafluoroethylene (Teflon)FDA Link 04/2009
1	Prednisolone (Predate)FDA LinkGeneric 04/2009
1	Dopamine D3 ReceptorsIBA 07/2008
1	valylvaline (Val-Val)IBA 04/2008
1	Indicators and Reagents (Reagents)IBA 10/2006

Therapy/Procedure

2	Electrodes (Electrode) 01/2014 - 01/2013
1	Intravenous Infusions 04/2017
1	Aftercare (After-Treatment) 04/2008